66
Participants
Start Date
December 31, 2003
Primary Completion Date
December 31, 2014
Study Completion Date
December 31, 2014
Fludarabine Phosphate
25 mg/m\^2 by vein over 5-30 minutes daily for 3 days (days 2-4)
Cyclophosphamide
250 mg/m\^2 by vein over 60 minutes daily for 3 days (days 2-4)
Rituximab
375 mg/m\^2 by vein for dose 1 (given 1 day prior to chemotherapy) and then 500 mg/m\^2 on days 2-3
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Genentech, Inc.
INDUSTRY
M.D. Anderson Cancer Center
OTHER